Search results
UBS Group Trims Amgen (NASDAQ:AMGN) Target Price to $284.00
ETF DAILY NEWS· 4 days agoAmgen (NASDAQ:AMGN – Free Report) had its price objective trimmed by UBS Group from $314.00 to $284.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently ...
AIA Group Ltd Decreases Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoAIA Group Ltd cut its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission ...
William Blair Comments on Amgen Inc.’s Q1 2024 Earnings (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Equities researchers at William Blair reduced their Q1 2024 earnings per share (EPS) estimates for Amgen in a research note issued on Wednesday, April ...
William Blair Comments on Biogen Inc.’s Q1 2024 Earnings (NASDAQ:BIIB)
ETF DAILY NEWS· 3 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at William Blair cut their Q1 2024 earnings estimates for shares of Biogen in a report issued on Wednesday, April 17th. William ...
Oppenheimer Lowers Biogen (NASDAQ:BIIB) Price Target to $270.00
ETF DAILY NEWS· 3 days agoBiogen (NASDAQ:BIIB – Get Free Report) had its price objective dropped by equities researchers at Oppenheimer from $290.00 to $270.00 in a research note issued on Friday, Benzinga reports. The ...